Concerns and debates regarding the effectiveness of weight loss medications are on the rise as obesity rates climb across various age groups. Following the approval of semaglutide (Wegovy) in 2021, these medications have seen a significant uptick in popularity. A study published in JAMA in late October 2024 indicated that the use of weight loss medications has doubled compared to a 25.6% decline in bariatric surgeries.
The study, which analyzed data from approximately 17 million individuals in the United States between 2022 and 2023, confirmed a substantial increase in demand for Wegovy, which is licensed for weight loss. However, its limited availability in the market has led many to seek alternatives like Ozempic, which is primarily used for treating type 2 diabetes.
Details of the Event
Ozempic has shown positive results in weight loss and has become a popular choice in the Arab world, despite its use still being based on unverified information or personal experiences. Many celebrities and social media influencers are leading campaigns promoting its use, further boosting its popularity among individuals looking to shed pounds.
However, the pressing question remains: Is Ozempic truly effective? What are its potential side effects? Responses to semaglutide medications vary from person to person, with a study (STEP 1 trial) showing that 86% of participants who took a weekly dose of 2.4 mg managed to lose 5% of their body weight.
Background & Context
A scientific review from the University of Jordan in 2025 indicated that the benefits of semaglutide medications, such as Ozempic, extend beyond weight loss. Studies have demonstrated their ability to improve liver health and cardiovascular health. They may also assist in managing polycystic ovary syndrome in women and provide kidney protection for diabetic patients.
Despite these benefits, researchers have warned about the unclear long-term effects of these medications on heart health, alongside reports of weight regain after discontinuation of treatment. A recent study in NEJM found that semaglutide might reduce mortality rates from serious heart issues, but the results were limited due to focusing on patients with a prior history of heart disease.
Impact & Consequences
Studies indicate that semaglutide medications may help lower high blood pressure, making them a potential option for treating hypertension in obese individuals. However, these findings are surrounded by several limitations, such as reliance on individual data that may affect the accuracy of results.
A Chinese study also identified an increased risk of gallbladder issues among users of these medications, which warrants caution. Nevertheless, research is ongoing to better understand the side effects.
Regional Significance
In the Arab world, where obesity rates have notably increased, Ozempic may represent a potential solution for many individuals. However, caution should be exercised regarding reliance on unverified information, and it is essential to consult healthcare professionals before starting any treatment regimen.
In conclusion, Ozempic and semaglutide medications remain a contentious topic, with benefits and risks varying widely. It is crucial for individuals to make informed decisions based on research and scientific studies.